181 related articles for article (PubMed ID: 16339811)
1. B-type natriuretic peptide can detect silent myocardial ischaemia in asymptomatic type 2 diabetes.
Rana BS; Davies JI; Band MM; Pringle SD; Morris A; Struthers AD
Heart; 2006 Jul; 92(7):916-20. PubMed ID: 16339811
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of B-type natriuretic peptide in patients with diabetes and acute decompensated heart failure.
Aspromonte N; Feola M; Milli M; Scardovi AB; Coletta C; Carbonieri E; Giovinazzo P; Di Giacomo T; Barro S; Rosso GL; Ceci V; Milani L; Valle R
Diabet Med; 2007 Feb; 24(2):124-30. PubMed ID: 17257273
[TBL] [Abstract][Full Text] [Related]
3. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus.
Bhalla MA; Chiang A; Epshteyn VA; Kazanegra R; Bhalla V; Clopton P; Krishnaswamy P; Morrison LK; Chiu A; Gardetto N; Mudaliar S; Edelman SV; Henry RR; Maisel AS
J Am Coll Cardiol; 2004 Sep; 44(5):1047-52. PubMed ID: 15337217
[TBL] [Abstract][Full Text] [Related]
6. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide and C-terminal-pro-endothelin-1 for the prediction of severely impaired peak oxygen consumption.
Maeder MT; Brutsche MH; Staub D; Morgenthaler NG; Bergmann A; Noveanu M; Laule K; Breidthardt T; Christ A; Klima T; Reichlin T; Potocki M; Mueller C
J Intern Med; 2009 May; 265(5):604-15. PubMed ID: 19226375
[TBL] [Abstract][Full Text] [Related]
8. Percent change in B-type natriuretic peptide levels during treadmill exercise as a screening test for exercise-induced myocardial ischemia.
Win HK; Chang SM; Raizner M; Shah G; Al Basky F; Desai U; Plana JC; Mahmarian JJ; Quinones MA; Zoghbi WA
Am Heart J; 2005 Oct; 150(4):695-700. PubMed ID: 16209968
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
Arquès S; Roux E; Sbragia P; Pieri B; Gélisse R; Luccioni R; Ambrosi P
Arch Mal Coeur Vaiss; 2007 Feb; 100(2):113-20. PubMed ID: 17474496
[TBL] [Abstract][Full Text] [Related]
10. Screening for heart disease in diabetic subjects.
Fang ZY; Schull-Meade R; Leano R; Mottram PM; Prins JB; Marwick TH
Am Heart J; 2005 Feb; 149(2):349-54. PubMed ID: 15846276
[TBL] [Abstract][Full Text] [Related]
11. Use of B-type natriuretic peptide in the detection of myocardial ischemia.
Staub D; Nusbaumer C; Zellweger MJ; Jonas N; Wild D; Pfisterer ME; Mueller-Brand J; Perruchoud AP; Mueller C
Am Heart J; 2006 Jun; 151(6):1223-30. PubMed ID: 16781223
[TBL] [Abstract][Full Text] [Related]
12. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G
G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.
Bal L; Thierry S; Brocas E; Van de Louw A; Pottecher J; Hours S; Moreau MH; Perrin Gachadoat D; Tenaillon A
Acta Anaesthesiol Scand; 2006 Mar; 50(3):340-7. PubMed ID: 16480468
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study).
O'Donoghue M; Kenney P; Oestreicher E; Anwaruddin S; Baggish AL; Krauser DG; Chen A; Tung R; Cameron R; Januzzi JL
Am J Cardiol; 2007 Nov; 100(9):1336-40. PubMed ID: 17950786
[TBL] [Abstract][Full Text] [Related]
15. Brain natriuretic peptide testing for angina in a rapid-access chest pain clinic.
Connolly SB; Collier T; Khugputh R; Tataree D; Kyereme K; Merritt S; Struthers AD; Fox KF
QJM; 2007 Dec; 100(12):779-83. PubMed ID: 17965439
[TBL] [Abstract][Full Text] [Related]
16. Cardiac risk scores in high-risk Hispanics and the predictive value of BNP.
Macabasco-O'Connell A; Danwalder S; Sinha K
J Clin Nurs; 2011 Nov; 20(21-22):3039-46. PubMed ID: 21592244
[TBL] [Abstract][Full Text] [Related]
17. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure.
Law YM; Ettedgui J; Beerman L; Maisel A; Tofovic S
Am J Cardiol; 2006 Aug; 98(4):520-4. PubMed ID: 16893709
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema.
Rana R; Vlahakis NE; Daniels CE; Jaffe AS; Klee GG; Hubmayr RD; Gajic O
Crit Care Med; 2006 Jul; 34(7):1941-6. PubMed ID: 16691132
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
